1. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
    Gan Huang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  2. Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines
    Gennaro Altamura et al, 2022, Frontiers in Veterinary Science CrossRef
  3. S5, a Withanolide Isolated from Physalis Pubescens L., Induces G2/M Cell Cycle Arrest via the EGFR/P38 Pathway in Human Melanoma A375 Cells
    Yuqi Fan et al, 2018, Molecules CrossRef
  4. Oridonin‐induced mitochondria‐dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways
    Jin‐Huan Jiang et al, 2019, Journal of Cellular Biochemistry CrossRef
  5. Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis
    Zhikun Zhan et al, 2022, Pharmacological Research CrossRef
  6. Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
    Xi Liu et al, 2021, Genes & Diseases CrossRef
  7. Recent advances in oridonin derivatives with anticancer activity
    Pedro J. M. Sobral et al, 2023, Frontiers in Chemistry CrossRef
  8. Selenium Nanoparticle in the Management of Oxidative Stress During Cancer Chemotherapy
    Ugir Hossain Sk et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  9. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells
    Ning Kang et al, 2020, Toxicology in Vitro CrossRef
  10. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform
    Yashar Mesbahi et al, 2018, European Journal of Pharmacology CrossRef
  11. Preliminary safety assessment of oridonin in zebrafish
    Lili Tian et al, 2019, Pharmaceutical Biology CrossRef
  12. Downregulation of XBP1 decreases serous ovarian cancer cell viability and enhances sensitivity to oxidative stress by increasing intracellular ROS levels
    Gui Zhang et al, 2019, Oncology Letters CrossRef
  13. Oridonin enhances TRAIL-induced apoptosis through GALNT14-mediated DR5 glycosylation
    Mi-Yeon Jeon et al, 2019, Biochimie CrossRef
  14. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
    Pierpaola Davalli et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  15. Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma
    Shijie Cao et al, 2019, Apoptosis CrossRef
  16. Phytotherapeutics oridonin and ponicidin show additive effects combined with irradiation in pancreatic cancer in vitro
    Jakob Liermann et al, 2017, Radiology and Oncology CrossRef
  17. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells
    Di Zhang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  18. Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy
    Yuan Liang et al, 2020, Pharmacological Research CrossRef
  19. Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
    Hanna-Riikka Teppo et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
  20. Induction of reactive oxygen species: an emerging approach for cancer therapy
    Zhengzhi Zou et al, 2017, Apoptosis CrossRef
  21. Preparation, Characterization and Anticancer Activity of Inclusion Complexes between Genistein and Amino‐Appended β‐Cyclodextrins
    Yazhou Zhang et al, 2022, ChemistrySelect CrossRef
  22. Oxidative Stress and Therapeutic Development in Lung Cancer
    Animesh Chowdhury et al, 2020, Oxidative Stress in Lung Diseases CrossRef
  23. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects
    Jingjing Li et al, 2019, Pharmacological Research CrossRef
  24. Expression and role of EGFR, cyclin�D1 and KRAS in laryngocarcinoma tissues
    Xinsheng Lin et al, 2018, Experimental and Therapeutic Medicine CrossRef
  25. Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia
    Xu Hu et al, 2020, Mini-Reviews in Medicinal Chemistry CrossRef
  26. Selenium Nanoparticle in the Management of Oxidative Stress During Cancer Chemotherapy
    Ugir Hossain Sk et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef